WebDec 6, 2024 · Provided herein are compounds that inhibit the phosphorylation of MAPK and thus are useful in compositions and methods for treating cancer and inflammatory disease. WebMar 3, 2024 · Sapience Therapeutics, Inc., a biotechnology company focused on the discovery and development of peptide therapeutics to address difficult-to-treat oncology indications, announced today that the U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) application for ST101, a peptide therapy …
Shy Therapeutics - Overview, News & Competitors ZoomInfo.com
WebSHY THERAPEUTICS, LLC (DOS ID 4795325) is a corporation registered with New York State Department of State (NYSDOS). The initial filling date is July 27, 2015. The address is 80 State Street, Albany, NEW YORK 12207-2543. WebApr 14, 2024 · -- Health care stocks were narrowly lower this afternoon, with the NYSE Health Care Index slipping 0.1% and the SPDR Health Care Select Sector ETF down 0.3% in late trade. The Nasdaq Biotechnology... April 1, 2024 جلسه mom چیست
Patents Assigned to SHY Therapeutics LLC - Justia
WebApr 7, 2024 · U.S. Patent Number 10588894 for Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease WebAlexion Pharmaceuticals, Inc. Precursor z (cpmp) to treat molybdenum cofactor deficiency type a CA3008171A1 (en) 2015-12-22: 2024-06-29: SHY Therapeutics LLC: Compounds for the treatment of cancer and inflammatory disease MX2024014875A (en) 2024-06-21: 2024-01-29: SHY Therapeutics LLC: Compounds that interact ... WebU.S. Patent Application 20240022074 for Compounds That Interact With The Ras Superfamily For The Treatment Of Cancers, Inflammatory Diseases, Rasopathies, And Fibrotic Disease جلسه g7